BEAZER HOMES USA INC (BZH)

US07556Q8814 - Common Stock

27.92  +0.12 (+0.43%)

After market: 27.92 0 (0%)

Fundamental Rating

4

Taking everything into account, BZH scores 4 out of 10 in our fundamental rating. BZH was compared to 66 industry peers in the Household Durables industry. BZH has a medium profitability rating, but doesn't score so well on its financial health evaluation. BZH has a decent growth rate and is not valued too expensively.



4

1. Profitability

1.1 Basic Checks

BZH had positive earnings in the past year.
BZH had a negative operating cash flow in the past year.
BZH had positive earnings in each of the past 5 years.
Of the past 5 years BZH 4 years had a positive operating cash flow.

1.2 Ratios

BZH's Return On Assets of 5.41% is in line compared to the rest of the industry. BZH outperforms 51.56% of its industry peers.
With a Return On Equity value of 11.38%, BZH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.53%, BZH is in line with its industry, outperforming 43.75% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BZH is below the industry average of 12.01%.
Industry RankSector Rank
ROA 5.41%
ROE 11.38%
ROIC 5.53%
ROA(3y)7.26%
ROA(5y)6.05%
ROE(3y)16.42%
ROE(5y)14.98%
ROIC(3y)8.4%
ROIC(5y)7.29%

1.3 Margins

Looking at the Profit Margin, with a value of 6.02%, BZH is in line with its industry, outperforming 51.56% of the companies in the same industry.
In the last couple of years the Profit Margin of BZH has grown nicely.
The Operating Margin of BZH (6.22%) is comparable to the rest of the industry.
BZH's Operating Margin has improved in the last couple of years.
The Gross Margin of BZH (18.29%) is worse than 84.38% of its industry peers.
In the last couple of years the Gross Margin of BZH has grown nicely.
Industry RankSector Rank
OM 6.22%
PM (TTM) 6.02%
GM 18.29%
OM growth 3Y-3.38%
OM growth 5Y17.22%
PM growth 3Y1.81%
PM growth 5YN/A
GM growth 3Y-1.13%
GM growth 5Y3.95%

3

2. Health

2.1 Basic Checks

BZH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BZH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BZH has more shares outstanding
The debt/assets ratio for BZH has been reduced compared to a year ago.

2.2 Solvency

BZH has an Altman-Z score of 2.60. This is not the best score and indicates that BZH is in the grey zone with still only limited risk for bankruptcy at the moment.
BZH's Altman-Z score of 2.60 is on the low side compared to the rest of the industry. BZH is outperformed by 60.94% of its industry peers.
BZH has a Debt/Equity ratio of 0.83. This is a neutral value indicating BZH is somewhat dependend on debt financing.
BZH's Debt to Equity ratio of 0.83 is on the low side compared to the rest of the industry. BZH is outperformed by 70.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Altman-Z 2.6
ROIC/WACC0.58
WACC9.5%

2.3 Liquidity

BZH has a Current Ratio of 7.81. This indicates that BZH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 7.81, BZH belongs to the top of the industry, outperforming 85.94% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that BZH may have some problems paying its short term obligations.
With a Quick ratio value of 0.91, BZH perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.81
Quick Ratio 0.91

5

3. Growth

3.1 Past

The earnings per share for BZH have decreased strongly by -12.55% in the last year.
The Earnings Per Share has been growing by 43.29% on average over the past years. This is a very strong growth
BZH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.60%.
The Revenue has been growing slightly by 2.22% on average over the past years.
EPS 1Y (TTM)-12.55%
EPS 3Y4.23%
EPS 5Y43.29%
EPS Q2Q%-6.11%
Revenue 1Y (TTM)5.6%
Revenue growth 3Y2.87%
Revenue growth 5Y2.22%
Sales Q2Q%24.91%

3.2 Future

The Earnings Per Share is expected to grow by 14.32% on average over the next years. This is quite good.
BZH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.41% yearly.
EPS Next Y1.71%
EPS Next 2Y14.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.71%
Revenue Next 2Y17.41%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.16 indicates a rather cheap valuation of BZH.
Compared to the rest of the industry, the Price/Earnings ratio of BZH indicates a rather cheap valuation: BZH is cheaper than 95.31% of the companies listed in the same industry.
BZH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
The Price/Forward Earnings ratio is 6.06, which indicates a rather cheap valuation of BZH.
Based on the Price/Forward Earnings ratio, BZH is valued cheaper than 95.31% of the companies in the same industry.
BZH is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.16
Fwd PE 6.06

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BZH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.56

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BZH does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BZH's earnings are expected to grow with 14.32% in the coming years.
PEG (NY)3.6
PEG (5Y)0.14
EPS Next 2Y14.32%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BZH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BEAZER HOMES USA INC

NYSE:BZH (12/20/2024, 8:04:00 PM)

After market: 27.92 0 (0%)

27.92

+0.12 (+0.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)01-30 2025-01-30/amc
Inst Owners85.96%
Inst Owner Change-2.6%
Ins Owners5.37%
Ins Owner Change-0.29%
Market Cap866.92M
Analysts87.5
Price Target43.35 (55.27%)
Short Float %5.79%
Short Ratio5.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.03%
Min EPS beat(2)4.35%
Max EPS beat(2)23.72%
EPS beat(4)3
Avg EPS beat(4)15.76%
Min EPS beat(4)-1.97%
Max EPS beat(4)36.94%
EPS beat(8)7
Avg EPS beat(8)24.7%
EPS beat(12)11
Avg EPS beat(12)30.19%
EPS beat(16)15
Avg EPS beat(16)35.14%
Revenue beat(2)1
Avg Revenue beat(2)0.87%
Min Revenue beat(2)-1.31%
Max Revenue beat(2)3.05%
Revenue beat(4)1
Avg Revenue beat(4)-3.57%
Min Revenue beat(4)-9.73%
Max Revenue beat(4)3.05%
Revenue beat(8)4
Avg Revenue beat(8)-0.2%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)8
Avg Revenue beat(16)0.15%
PT rev (1m)0%
PT rev (3m)11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48.96%
EPS NY rev (1m)-6.66%
EPS NY rev (3m)-6.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.64%
Revenue NY rev (1m)1.89%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 6.16
Fwd PE 6.06
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.71
EV/EBITDA 10.56
EPS(TTM)4.53
EY16.22%
EPS(NY)4.61
Fwd EY16.5%
FCF(TTM)-5.15
FCFYN/A
OCF(TTM)-4.43
OCFYN/A
SpS75.05
BVpS39.68
TBVpS39.32
PEG (NY)3.6
PEG (5Y)0.14
Profitability
Industry RankSector Rank
ROA 5.41%
ROE 11.38%
ROCE 6.32%
ROIC 5.53%
ROICexc 6.07%
ROICexgc 6.24%
OM 6.22%
PM (TTM) 6.02%
GM 18.29%
FCFM N/A
ROA(3y)7.26%
ROA(5y)6.05%
ROE(3y)16.42%
ROE(5y)14.98%
ROIC(3y)8.4%
ROIC(5y)7.29%
ROICexc(3y)9.56%
ROICexc(5y)8.41%
ROICexgc(3y)9.76%
ROICexgc(5y)8.56%
ROCE(3y)9.6%
ROCE(5y)8.34%
ROICexcg growth 3Y-9.53%
ROICexcg growth 5Y14.5%
ROICexc growth 3Y-9.92%
ROICexc growth 5Y14.16%
OM growth 3Y-3.38%
OM growth 5Y17.22%
PM growth 3Y1.81%
PM growth 5YN/A
GM growth 3Y-1.13%
GM growth 5Y3.95%
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF N/A
Debt/EBITDA 6.41
Cap/Depr 150.35%
Cap/Sales 0.96%
Interest Coverage 1.93
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.81
Quick Ratio 0.91
Altman-Z 2.6
F-Score4
WACC9.5%
ROIC/WACC0.58
Cap/Depr(3y)142.9%
Cap/Depr(5y)120.18%
Cap/Sales(3y)0.84%
Cap/Sales(5y)0.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.55%
EPS 3Y4.23%
EPS 5Y43.29%
EPS Q2Q%-6.11%
EPS Next Y1.71%
EPS Next 2Y14.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.6%
Revenue growth 3Y2.87%
Revenue growth 5Y2.22%
Sales Q2Q%24.91%
Revenue Next Year20.71%
Revenue Next 2Y17.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.44%
EBIT growth 3Y-0.61%
EBIT growth 5Y19.83%
EBIT Next Year109.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-201.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.23%
OCF growth 3YN/A
OCF growth 5YN/A